Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442)
Public ClinicalTrials.gov record NCT00849290. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
AN OPEN LABEL, SINGLE ARM TRIAL OF IMMUNOTHERAPY WITH AUTOLOGOUS ANTIGEN PRESENTING CELLS LOADED WITH PA2024 (APC8015F) FOR MEN WITH OBJECTIVE DISEASE PROGRESSION ON PROTOCOL D9902 PART B
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is an open label, Phase 2 trial of APC8015F immunotherapy in men with objective disease progression on protocol D9902 part B (NCT00065442)
Study identification
- NCT ID
- NCT00849290
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 113 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2004 (Type not available)
- Primary completion
- Jan 2009 (Actual)
- Completion
- Apr 2009 (Actual)
- Last update posted
- Nov 29, 2023
2004 – 2009
United States locations
- U.S. sites
- 53
- U.S. states
- 23
- U.S. cities
- 43
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCLA | Los Angeles | California | — | — |
| USC Keck School of Medicine | Los Angeles | California | — | — |
| Sutter Cancer Center | Sacramento | California | — | — |
| Kaiser Permanente Medical Group | San Diego | California | — | — |
| Sharp HealthCare | San Diego | California | — | — |
| UCSF Cancer Center | San Francisco | California | — | — |
| Helen F. Graham Cancer Center | Newark | Delaware | — | — |
| Lombardi Cancer Center | Washington D.C. | District of Columbia | — | — |
| Walter Reid Army Medical Center | Washington D.C. | District of Columbia | — | — |
| Miami Cancer Center | Miami | Florida | — | — |
| Hematology/Oncology Associates of the Treasure Coast | Port Saint Lucie | Florida | — | — |
| Georgia Urology, P.A. | Atlanta | Georgia | — | — |
| Midwest Prostate & Urology Health Center | Chicago | Illinois | — | — |
| Loyola University | Maywood | Illinois | — | — |
| Lutheran General Cancer Center | Park Ridge | Illinois | — | — |
| Indiana University | Indianapolis | Indiana | — | — |
| Myron I Murdock MD LLC | Greenbelt | Maryland | — | — |
| Dana-Farber Cancer Institute | Boston | Massachusetts | — | — |
| Lahey Clinic (Department of Urology) | Burlington | Massachusetts | — | — |
| University of Minnesota | Minneapolis | Minnesota | — | — |
| Mayo Clinic | Rochester | Minnesota | — | — |
| Nevada Cancer Institute | Las Vegas | Nevada | — | — |
| Hackensack University Medical Center | Hackensack | New Jersey | — | — |
| Associates in Urology, LLC | West Orange | New Jersey | — | — |
| Albany Regional Cancer Center | Albany | New York | — | — |
| The Urological Institute of Northeastern New York | Albany | New York | — | — |
| North Shore Hematology Oncology Associates | East Setauket | New York | — | — |
| New York Medical College | Hawthorne | New York | — | — |
| Beth Israel Cancer Center | New York | New York | — | — |
| Clinical Cancer Center | New York | New York | — | — |
| Mount Sinai School of Medicine | New York | New York | — | — |
| New York University | New York | New York | — | — |
| Staten Island Urological Research | Staten Island | New York | — | — |
| McKay Urology | Charlotte | North Carolina | — | — |
| Duke University Medical Center | Durham | North Carolina | — | — |
| University of Cincinnati | Cincinnati | Ohio | — | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | — | — |
| EACRI | Portland | Oregon | — | — |
| Kaiser Permanente Medical Group | Portland | Oregon | — | — |
| Center for Urologic Care | Bryn Mawr | Pennsylvania | — | — |
| Jefferson Medical College | Philadelphia | Pennsylvania | — | — |
| Grand Strand Urology | Myrtle Beach | South Carolina | — | — |
| Mary Crowley | Dallas | Texas | — | — |
| Baylor College of Medicine | Houston | Texas | — | — |
| University of Utah | Salt Lake City | Utah | — | — |
| Urology of Virginia, PC | Norfolk | Virginia | — | — |
| Seattle Cancer Care Alliance | Seattle | Washington | — | — |
| Virginia Mason Medical Center | Seattle | Washington | — | — |
| Cancer Care Northwest | Spokane | Washington | — | — |
| Wenatchee Valley Medical Center | Wenatchee | Washington | — | — |
| University of Wisconsin, Madison | Madison | Wisconsin | — | — |
| University of Wisconsin | Madison | Wisconsin | — | — |
| St. Luke's Hospital Immunotherapy Program | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00849290, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 29, 2023 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00849290 live on ClinicalTrials.gov.